DNER and ovarian carcinoma: The association between BET inhibitor resistance and autophagy induction reported by Luan et al. [47] in ovarian carcinoma and Jang et al. [67] in leukemia suggests that autophagy may play a role in the development of resistance and, consequently, that BET targeting may represent a productive clinical strategy.